{ "cik": 1177648, "cik_padded": "0001177648", "entityName": "ENANTA PHARMACEUTICALS INC", "fiscal_years": [ { "accn": "0001193125-25-288121", "filed": "2025-11-19", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 12896000.0, "cash": 32298000.0, "eps_diluted": -3.84, "free_cash_flow": -32168000.0, "net_income": -81889000.0, "operating_cash_flow": -19272000.0, "operating_income": -85349000.0, "revenue": 65324000.0, "stockholders_equity": 64717000.0, "total_assets": 280732000.0, "total_liabilities": 216015000.0 }, "period_end": "2025-09-30", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 3.3378401347404854, "net_margin": -1.2535821443879738, "operating_margin": -1.306548894740065, "revenue_growth_yoy": -0.034168699637761514, "roa_avg2y": -0.24913596923563702, "roa_period_end": -0.29169813202627415, "roe_avg2y": -0.8462623559016385, "roe_period_end": -1.265339864332401 } }, { "accn": "0001193125-25-288121", "filed": "2025-11-19", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 17948000.0, "cash": 37233000.0, "eps_diluted": -5.48, "free_cash_flow": -96712000.0, "net_income": -116045000.0, "operating_cash_flow": -78764000.0, "operating_income": -121691000.0, "revenue": 67635000.0, "stockholders_equity": 128814000.0, "total_assets": 376652000.0, "total_liabilities": 247838000.0 }, "period_end": "2024-09-30", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.9239989442141383, "revenue_growth_yoy": -0.14606585525983537, "roa_avg2y": -0.27665100777540835, "roa_period_end": -0.3080960674574939, "roe_avg2y": -0.6716558288404828, "roe_period_end": -0.90087257596224 } }, { "accn": "0001193125-25-288121", "filed": "2025-11-19", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 9058000.0, "cash": 85388000.0, "eps_diluted": -6.38, "free_cash_flow": -112212000.0, "net_income": -133816000.0, "operating_cash_flow": -103154000.0, "operating_income": -137207000.0, "revenue": 79204000.0, "stockholders_equity": 216735000.0, "total_assets": 462275000.0, "total_liabilities": 245540000.0 }, "period_end": "2023-09-30", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.1329042378942027, "revenue_growth_yoy": -0.08073351903435469, "roa_avg2y": -0.3194900230993751, "roa_period_end": -0.28947271645665457, "roe_avg2y": -0.4973934569729905, "roe_period_end": -0.6174175836851454 } }, { "accn": "0001193125-25-288121", "filed": "2025-11-19", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2125000.0, "cash": 43994000.0, "eps_diluted": -5.91, "free_cash_flow": -86907000.0, "net_income": -121755000.0, "operating_cash_flow": -84782000.0, "operating_income": -123844000.0, "revenue": 86160000.0, "stockholders_equity": 321334000.0, "total_assets": 375410000.0, "total_liabilities": 54076000.0 }, "period_end": "2022-09-30", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1682859579129504, "net_margin": -1.4131267409470751, "operating_margin": -1.4373723305478179, "revenue_growth_yoy": -0.11242969281166945, "roa_avg2y": -0.2990784830772745, "roa_period_end": -0.3243254042247143, "roe_avg2y": -0.3378503058564327, "roe_period_end": -0.37890481555017513 } }, { "accn": "0000950170-24-131260", "filed": "2024-11-27", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 750000.0, "cash": 57206000.0, "eps_diluted": -3.92, "free_cash_flow": -70746000.0, "net_income": -78996000.0, "operating_cash_flow": -69996000.0, "operating_income": -109573000.0, "revenue": 97074000.0, "stockholders_equity": 399429000.0, "total_assets": 438791000.0, "total_liabilities": 39362000.0 }, "period_end": "2021-09-30", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.098545673949563, "net_margin": -0.8137709376352062, "operating_margin": -1.1287574427756144, "revenue_growth_yoy": -0.20738448474357613, "roa_avg2y": -0.17081638147175496, "roa_period_end": -0.1800310398344542, "roe_avg2y": -0.18478401981733525, "roe_period_end": -0.1977723199867811 } }, { "accn": "0000950170-23-065884", "filed": "2023-11-22", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1445000.0, "cash": 87131000.0, "eps_diluted": -1.81, "free_cash_flow": 5643000.0, "net_income": -36168000.0, "operating_cash_flow": 7088000.0, "operating_income": -41639000.0, "revenue": 122473000.0, "stockholders_equity": 455580000.0, "total_assets": 486132000.0, "total_liabilities": 30552000.0 }, "period_end": "2020-09-30", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.06706176741735809, "net_margin": -0.2953140692234207, "operating_margin": -0.33998513958178544, "revenue_growth_yoy": -0.4031442954819028, "roa_avg2y": -0.07411771576938013, "roa_period_end": -0.07439954580237466, "roe_avg2y": -0.07879120591849005, "roe_period_end": -0.0793889108389306 } }, { "accn": "0001564590-20-055233", "filed": "2022-11-23", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 5417000.0, "cash": 51230000.0, "eps_diluted": 2.21, "free_cash_flow": 66001000.0, "net_income": 46383000.0, "operating_cash_flow": 71418000.0, "operating_income": 36738000.0, "revenue": 205197000.0, "stockholders_equity": 462492000.0, "total_assets": 489829000.0, "total_liabilities": 27337000.0 }, "period_end": "2019-09-30", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.05910804943653079, "net_margin": 0.22604131639351452, "operating_margin": 0.17903770522960863, "revenue_growth_yoy": -0.006911070780399274, "roa_avg2y": 0.10261090020972152, "roa_period_end": 0.09469222932901074, "roe_avg2y": 0.108349850672354, "roe_period_end": 0.10028930230144521 } }, { "accn": "0001564590-20-055233", "filed": "2021-11-24", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2981000.0, "cash": 63902000.0, "eps_diluted": 3.48, "free_cash_flow": 26239000.0, "net_income": 71956000.0, "operating_cash_flow": 29220000.0, "operating_income": 88328000.0, "revenue": 206625000.0, "stockholders_equity": 393679000.0, "total_assets": 414227000.0, "total_liabilities": 20548000.0 }, "period_end": "2018-09-30", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.052194808460700216, "net_margin": 0.3482444041137326, "operating_margin": 0.4274797338173018, "revenue_growth_yoy": 1.009697122959908, "roa_avg2y": 0.19424887698686938, "roa_period_end": 0.17371151566653067, "roe_avg2y": 0.20696191154158666, "roe_period_end": 0.18277835495416317 } }, { "accn": "0001564590-20-055233", "filed": "2020-11-25", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2506000.0, "cash": 65675000.0, "eps_diluted": 0.91, "free_cash_flow": 50147000.0, "net_income": 17710000.0, "operating_cash_flow": 52653000.0, "operating_income": 24614000.0, "revenue": 102814000.0, "stockholders_equity": 301676000.0, "total_assets": 326637000.0, "total_liabilities": 24961000.0 }, "period_end": "2017-09-30", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.08274108646362323, "net_margin": 0.1722528060380882, "operating_margin": 0.23940319411753264, "revenue_growth_yoy": 0.16479358317850185, "roa_avg2y": 0.05826482035287886, "roa_period_end": 0.0542192097037384, "roe_avg2y": 0.06196510919994682, "roe_period_end": 0.05870536602182474 } }, { "accn": "0001564590-19-044729", "filed": "2019-11-27", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 4738000.0, "cash": 16577000.0, "eps_diluted": 1.13, "free_cash_flow": 31071000.0, "net_income": 21666000.0, "operating_cash_flow": 35809000.0, "operating_income": 30841000.0, "revenue": 88268000.0, "stockholders_equity": 269936000.0, "total_assets": 281277000.0, "total_liabilities": 11341000.0 }, "period_end": "2016-09-30", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.04201366249777725, "net_margin": 0.2454570172656002, "operating_margin": 0.3494018217247474, "roa_period_end": 0.07702727204855, "roe_period_end": 0.08026346985952226 } } ], "latest_filing": { "accn": "0001193125-25-288121", "filed": "2025-11-19", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001177648.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001177648.json" }, "ticker": "ENTA" }